scispace - formally typeset
K

Kaixian Chen

Researcher at Chinese Academy of Sciences

Publications -  403
Citations -  11476

Kaixian Chen is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Virtual screening & Chemistry. The author has an hindex of 47, co-authored 380 publications receiving 9209 citations. Previous affiliations of Kaixian Chen include Shanghai University & East China University of Science and Technology.

Papers
More filters
Journal ArticleDOI

Rapid and Efficient Pd-Catalyzed Sonogashira Coupling of Aryl Chlorides.

TL;DR: An efficient and effective microwave-assisted cross-coupling of terminal alkynes with various aryl chlorides including sterically hindered, electron-rich, electron neutral, and electron-deficient is developed in this article.
Posted ContentDOI

Computational target fishing by mining transcriptional data using a novel Siamese spectral-based graph convolutional network

TL;DR: A novel Siamese spectral-based graph convolutional network model for inferring the protein targets of chemical compounds from gene transcriptional profiles that was successfully trained to learn from known compound-target pairs by uncovering the hidden correlations between compound perturbation profiles and gene knockdown profiles.
Journal Article

[A new practical route to stereospecific synthesis of (S)-(-)-ofloxacin].

TL;DR: A new facile practical route with good yield and high optical purity to stereospecific synthesis of (S)-(-)-ofloxacin was described.
Journal Article

Binding conformers searching method for ligands according to the structures of their receptors and its application to thrombin inhibitors.

TL;DR: Both of the total binding energies and steric binding energies have good correlations with the inhibitory activities of these thrombin inhibitors, demonstrating that the binding conformer searching method for ligands is reasonable.
Patent

Benzopyranone derivatives and their use as anti-coronaviral agents

TL;DR: In this article, pharmaceutical compositions comprising benzopyranone derivatives for the treatment of Severe Acute Respiratory Syndrome (SARS) were described. But none of the compositions were tested on humans.